Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 2 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 14, 2021 16:10 UTC |
ADAMS THOMAS PHDFormer Director
|
OtherStock Options · Derivative | 530 | $0.00 Strike: $51.84 | $0.00 |
DisclosureSEC source: 0001628280-21-012169 · wf-form4_162370142446711.xml · derivative · entry 4 ADAMS THOMAS PHD · CIK 0001234366 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,870 Underlying: Common Stock · 530 shares Expires 2023-06-10 F1 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 16:10 UTC |
ADAMS THOMAS PHDFormer Director
|
OtherStock Options · Derivative | 223 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001628280-21-012169 · wf-form4_162370142446711.xml · derivative · entry 3 ADAMS THOMAS PHD · CIK 0001234366 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,870 Underlying: Common Stock · 223 shares Expires 2023-06-10 F1 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 16:10 UTC |
ADAMS THOMAS PHDFormer Director
|
OtherStock Options · Derivative | 223 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0001628280-21-012169 · wf-form4_162370142446711.xml · derivative · entry 2 ADAMS THOMAS PHD · CIK 0001234366 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,870 Underlying: Common Stock · 223 shares Expires 2023-06-10 F1 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 16:10 UTC |
ADAMS THOMAS PHDFormer Director
|
OtherStock Options · Derivative | 272 | $0.00 Strike: $447.84 | $0.00 |
DisclosureSEC source: 0001628280-21-012169 · wf-form4_162370142446711.xml · derivative · entry 1 ADAMS THOMAS PHD · CIK 0001234366 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,870 Underlying: Common Stock · 272 shares Expires 2023-06-10 F1 · kind: Expiration date of the stock options was extended to June 10, 2023. F2 · derivative.exercise_date: 7,338 of the stock options vest immediately. 4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:13 UTC |
PACE GARY WDirector
|
GrantStock Options · Derivative | 22,000 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001628280-21-012176 · wf-form4_162370157658233.xml · derivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,774 Underlying: Common Stock · 22,000 shares Expires 2031-06-10 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:13 UTC |
TANNENBAUM RENEE PDirector
|
GrantStock Options · Derivative | 44,001 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001628280-21-012177 · wf-form4_162370159154248.xml · derivative · entry 1 TANNENBAUM RENEE P · CIK 0001543174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,001 Underlying: Common Stock · 44,001 shares Expires 2031-06-10 F1 · derivative.exercise_date: 14,667 vest on 6/10/2022, 6/10/2023, and 6/20/2024 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:14 UTC |
White LaleDirector
|
GrantStock Options · Derivative | 22,000 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001628280-21-012178 · wf-form4_162370162899357.xml · derivative · entry 1 White Lale · CIK 0001635493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,774 Underlying: Common Stock · 22,000 shares Expires 2031-06-10 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:12 UTC |
Mohindru ManiDirector
|
GrantStock Options · Derivative | 44,001 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001628280-21-012175 · wf-form4_162370155455648.xml · derivative · entry 1 Mohindru Mani · CIK 0001664708 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,001 Underlying: Common Stock · 44,001 shares Expires 2031-06-10 F1 · derivative.exercise_date: 14,667 vest on 6/10/2022, 6/10/2023, and 6/20/2024 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:12 UTC |
Markin Rodney SDirector
|
GrantStock Options · Derivative | 22,000 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001628280-21-012174 · wf-form4_162370153475601.xml · derivative · entry 1 Markin Rodney S · CIK 0001393415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,827 Underlying: Common Stock · 22,000 shares Expires 2031-06-10 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:11 UTC |
BRANCACCIO JOHN PDirector
|
GrantStock Options · Derivative | 22,000 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001628280-21-012171 · wf-form4_162370147280131.xml · derivative · entry 1 BRANCACCIO JOHN P · CIK 0001276551 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,517 Underlying: Common Stock · 22,000 shares Expires 2031-06-10 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:11 UTC |
Armitage James ODirector
|
GrantStock Options · Derivative | 22,000 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001628280-21-012170 · wf-form4_162370144457487.xml · derivative · entry 1 Armitage James O · CIK 0001370087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,774 Underlying: Common Stock · 22,000 shares Expires 2031-06-10 Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 44,734 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 8 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 44,734 shares Expires 2023-06-10 F2 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 755 | $0.00 Strike: $21.60 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 7 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 755 shares Expires 2023-06-10 F2 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 530 | $0.00 Strike: $51.84 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 6 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 530 shares Expires 2023-06-10 F2 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 223 | $0.00 Strike: $372.96 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 5 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 223 shares Expires 2023-06-10 F2 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 223 | $0.00 Strike: $516.96 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 4 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 223 shares Expires 2023-06-10 F2 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 218 | $0.00 Strike: $316.08 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 3 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 218 shares Expires 2023-06-10 F2 · kind: Expiration date of the stock options was extended to June 10, 2023. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 293 | $0.00 Strike: $447.84 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 2 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 293 shares Expires 2023-06-10 F2 · kind: Expiration date of the stock options was extended to June 10, 2023. F3 · derivative.exercise_date: 8,805 of the stock options vest immediately. 4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017. Read SEC document |
| June 10, 2021 Filed Jun 15, 2021 14:06 UTC |
JACOB GARY SFormer Director
|
OtherStock Options · Derivative | 28,858 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001628280-21-012225 · wf-form4_162376598346799.xml · derivative · entry 1 JACOB GARY S · CIK 0001266802 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 28,858 shares Expires 2023-06-10 F1 · kind: In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 28,858 stock options to June 10, 2021 from June 17, 2021. In addition, the Compensation Committee extended the expiration date of the stock options to June 10, 2023. Read SEC document |
| March 26, 2021 Filed Mar 29, 2021 17:38 UTC |
Markin Rodney SDirector
|
PurchaseCommon Stock | 2,900 | $10.32 | $29,933.22 |
DisclosureSEC source: 0001628280-21-005926 · wf-form4_161703951417179.xml · nonDerivative · entry 1 Markin Rodney S · CIK 0001393415 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Fund Disclosed balance after: 23,879 F1 · ownership.nature: Through Prairie Ventures, LLC Read SEC document |
| March 23, 2021 Filed Mar 23, 2021 14:30 UTC |
Kelemen VickiExec. VP and COO
|
PurchaseCommon Stock | 960 | $10.31 | $9,897.60 |
DisclosureSEC source: 0001628280-21-005343 · wf-form4_161652421851684.xml · nonDerivative · entry 1 Kelemen Vicki · CIK 0001815809 · Exec. VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,053 Read SEC document |
| March 23, 2021 Filed Mar 23, 2021 12:24 UTC |
Erlander MarkChief Executive Officer
|
PurchaseCommon Stock | 965 | $10.34 | $9,979.74 |
DisclosureSEC source: 0001628280-21-005335 · wf-form4_161651662768276.xml · nonDerivative · entry 1 Erlander Mark · CIK 0001651537 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,481 Read SEC document |
| March 23, 2021 Filed Mar 23, 2021 19:57 UTC |
JACOB GARY SDirector
|
PurchaseCommon Stock | 470 | $10.40 | $4,885.65 |
DisclosureSEC source: 0001628280-21-005358 · wf-form4_161652942189444.xml · nonDerivative · entry 2 JACOB GARY S · CIK 0001266802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,922 Read SEC document |
| March 23, 2021 Filed Mar 23, 2021 19:57 UTC |
JACOB GARY SDirector
|
PurchaseCommon Stock | 1,900 | $10.42 | $19,803.70 |
DisclosureSEC source: 0001628280-21-005358 · wf-form4_161652942189444.xml · nonDerivative · entry 1 JACOB GARY S · CIK 0001266802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,452 Read SEC document |
| March 23, 2021 Filed Mar 24, 2021 14:27 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 2,500 | $10.31 | $25,775.00 |
DisclosureSEC source: 0001628280-21-005426 · wf-form4_161659603050590.xml · nonDerivative · entry 3 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,811 Read SEC document |
| March 23, 2021 Filed Mar 24, 2021 14:27 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 2,500 | $10.21 | $25,525.00 |
DisclosureSEC source: 0001628280-21-005426 · wf-form4_161659603050590.xml · nonDerivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,311 Read SEC document |
| March 23, 2021 Filed Mar 24, 2021 14:27 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 5,000 | $10.20 | $51,000.00 |
DisclosureSEC source: 0001628280-21-005426 · wf-form4_161659603050590.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,811 Read SEC document |
| March 22, 2021 Filed Mar 22, 2021 22:35 UTC |
BRANCACCIO JOHN PDirector
|
PurchaseCommon Stock | 3,000 | $10.95 | $32,850.00 |
DisclosureSEC source: 0001628280-21-005297 · wf-form4_161645252417136.xml · nonDerivative · entry 1 BRANCACCIO JOHN P · CIK 0001276551 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,260 Read SEC document |
| March 19, 2021 Filed May 27, 2021 21:14 UTC |
Armitage James ODirector
|
PurchaseCommon Stock | 4,000 | $10.82 | $43,271.20 |
DisclosureSEC source: 0001628280-21-011230 · wf-form4_162215000508271.xml · nonDerivative · entry 1 Armitage James O · CIK 0001370087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,490 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.795 to $10.82, inclusive. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 15:34 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 2,000 | $10.54 | $21,080.00 |
DisclosureSEC source: 0001628280-21-005156 · wf-form4_161616808093613.xml · nonDerivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,811 Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 15:34 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 1,000 | $10.58 | $10,580.00 |
DisclosureSEC source: 0001628280-21-005156 · wf-form4_161616808093613.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,811 Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 01:46 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 1,500 | $9.27 | $13,897.50 |
DisclosureSEC source: 0001628280-21-003990 · wf-form4_161490878112223.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,811 Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 16:04 UTC |
Kelemen VickiExec. VP and COO
|
Exercise / conversionRestricted Stock Units · Derivative | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-000061 · wf-form4_160988062663348.xml · derivative · entry 3 Kelemen Vicki · CIK 0001815809 · Exec. VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Cardiff Oncology, Inc. common stock. F4 · derivative.exercise_date: On January 4, 2017, the reporting person was granted 278 restricted stock units, 70 of which vested on January 2, 2021. The common stock into which such vested restricted stock units converted on January 2, 2021 is reported in Table I on this Form 4. F4 · derivative.expiration_date: On January 4, 2017, the reporting person was granted 278 restricted stock units, 70 of which vested on January 2, 2021. The common stock into which such vested restricted stock units converted on January 2, 2021 is reported in Table I on this Form 4. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 16:04 UTC |
Kelemen VickiExec. VP and COO
|
Tax withholdingCommon Stock | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-000061 · wf-form4_160988062663348.xml · nonDerivative · entry 2 Kelemen Vicki · CIK 0001815809 · Exec. VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,093 F2 · shares: The reporting person is reporting the withholding by Cardiff Oncology, Inc. of 31 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on January 4, 2021. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 16:04 UTC |
Kelemen VickiExec. VP and COO
|
Exercise / conversionCommon Stock | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-000061 · wf-form4_160988062663348.xml · nonDerivative · entry 1 Kelemen Vicki · CIK 0001815809 · Exec. VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 4, 2017, the reporting person was granted 1,459 restricted stock units, 261 of which vested on January 2, 2020. Such restricted stock units were previously reported in Table II on a Form 3 filed with the Securities and Exchange Commission on June 22, 2020. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 16:03 UTC |
Erlander MarkChief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 260 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-000060 · wf-form4_160988059527289.xml · derivative · entry 3 Erlander Mark · CIK 0001651537 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 260 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Cardiff Oncology, Inc. common stock. F4 · derivative.exercise_date: On January 4, 2017, the reporting person was granted 1,459 restricted stock units, 260 of which vested on January 2, 2021. The common stock into which such vested restricted stock units converted on January 2, 2021 is reported in Table I on this Form 4. F4 · derivative.expiration_date: On January 4, 2017, the reporting person was granted 1,459 restricted stock units, 260 of which vested on January 2, 2021. The common stock into which such vested restricted stock units converted on January 2, 2021 is reported in Table I on this Form 4. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 16:03 UTC |
Erlander MarkChief Executive Officer
|
Tax withholdingCommon Stock | 113 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-000060 · wf-form4_160988059527289.xml · nonDerivative · entry 2 Erlander Mark · CIK 0001651537 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,516 F2 · shares: The reporting person is reporting the withholding by Cardiff Oncology, Inc. of 113 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on January 4, 2021. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 16:03 UTC |
Erlander MarkChief Executive Officer
|
Exercise / conversionCommon Stock | 260 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-000060 · wf-form4_160988059527289.xml · nonDerivative · entry 1 Erlander Mark · CIK 0001651537 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 4, 2017, the reporting person was granted 1,459 restricted stock units, 261 of which vested on January 2, 2020. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 4, 2017. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 16:02 UTC |
Kelemen VickiExec. VP and COO
|
Exercise / conversionStock Options · Derivative | 35,321 | $2.48 Strike: $2.48 | $87,596.08 |
DisclosureSEC source: 0001628280-20-016822 · wf-form4_160633815218613.xml · derivative · entry 3 Kelemen Vicki · CIK 0001815809 · Exec. VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,641 Underlying: Common Stock · 35,321 shares Expires 2029-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 35,321 options vested on 6/20/2020. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 16:02 UTC |
Kelemen VickiExec. VP and COO
|
SaleCommon Stock | 35,321 | $18.60 | $657,020.05 |
DisclosureSEC source: 0001628280-20-016822 · wf-form4_160633815218613.xml · nonDerivative · entry 2 Kelemen Vicki · CIK 0001815809 · Exec. VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,054 F1 · price: The common stock was sold by the reporting person in a series of open market transactions on the transaction date at a weighted average sale price of $18.6014. The range of prices was $18.40 to $19.25. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares sold at each price. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 16:02 UTC |
Kelemen VickiExec. VP and COO
|
Exercise / conversionCommon Stock | 35,321 | $2.48 | $87,596.08 |
DisclosureSEC source: 0001628280-20-016822 · wf-form4_160633815218613.xml · nonDerivative · entry 1 Kelemen Vicki · CIK 0001815809 · Exec. VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 13:42 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 850 | $5.71 | $4,853.50 |
DisclosureSEC source: 0001628280-20-013688 · wf-form4_160035013609004.xml · nonDerivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,311 Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 13:42 UTC |
PACE GARY WDirector
|
PurchaseCommon Stock | 1,700 | $5.69 | $9,673.00 |
DisclosureSEC source: 0001628280-20-013688 · wf-form4_160035013609004.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,461 Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:15 UTC |
Erlander MarkDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 221,241 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001104659-20-075234 · a4.xml · derivative · entry 1 Erlander Mark · CIK 0001651537 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,200 Underlying: Common Stock · 221,241 shares Expires 2030-06-17 F1 · derivative.exercise_date: 73,747 vest on each of 6/17/2021, 2022 and 2023. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:16 UTC |
JACOB GARY SDirector
|
GrantStock Options · Derivative | 28,858 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001104659-20-075237 · a4.xml · derivative · entry 1 JACOB GARY S · CIK 0001266802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,106 Underlying: Common Stock · 28,858 shares Expires 2030-06-17 Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:15 UTC |
ADAMS THOMAS PHDDirector · Executive Chairman
|
GrantStock Options · Derivative | 173,145 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001104659-20-075230 · a4.xml · derivative · entry 1 ADAMS THOMAS PHD · CIK 0001234366 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,870 Underlying: Common Stock · 173,145 shares Expires 2030-06-17 F1 · derivative.exercise_date: 57,715 vest on each of June 17, 2021, 2022 and 2023. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:17 UTC |
PACE GARY WDirector
|
GrantStock Options · Derivative | 28,858 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001104659-20-075244 · a4.xml · derivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,774 Underlying: Common Stock · 28,858 shares Expires 2030-06-17 Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:17 UTC |
Armitage James ODirector
|
GrantStock Options · Derivative | 28,858 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001104659-20-075242 · a4.xml · derivative · entry 1 Armitage James O · CIK 0001370087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,774 Underlying: Common Stock · 28,858 shares Expires 2030-06-17 Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:16 UTC |
White LaleDirector
|
GrantStock Options · Derivative | 28,858 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001104659-20-075240 · a4.xml · derivative · entry 1 White Lale · CIK 0001635493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,774 Underlying: Common Stock · 28,858 shares Expires 2030-06-17 Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:15 UTC |
Markin Rodney SDirector
|
GrantStock Options · Derivative | 28,858 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001104659-20-075232 · a4.xml · derivative · entry 1 Markin Rodney S · CIK 0001393415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,827 Underlying: Common Stock · 28,858 shares Expires 2030-06-17 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.